The Technical Analyst
Select Language :
Gilead Sciences Inc [GILD]

Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—General

Gilead Sciences Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Gilead Sciences Inc is listed at the  Exchange

0.33% $73.25

America/New_York / 28 mar 2024 @ 16:00


Gilead Sciences Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 91 253 mill
EPS: 4.50
P/E: 16.28
Earnings Date: Apr 25, 2024
SharesOutstanding: 1 245.77 mill
Avg Daily Volume: 7.53 mill
RATING 2024-03-28
S
Strong Buy
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Buy
Return On Asset: Strong Buy
DE: Strong Buy
P/E: Strong Buy
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 16.28 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
0.84x
Company: PE 16.28 | industry: PE 19.30
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 71.98 - 74.52

( +/- 1.73%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-10 Telman Deborah H Buy 54 980 Non-qualified Stock Option (Right to Buy)
2024-03-10 Telman Deborah H Buy 10 815 Restricted Stock Unit
2024-03-10 Telman Deborah H Sell 2 555 Restricted Stock Unit
2024-03-10 Telman Deborah H Buy 2 555 Common Stock
2024-03-10 Telman Deborah H Sell 846 Common Stock
INSIDER POWER
62.04
Last 99 transactions
Buy: 1 293 733 | Sell: 313 353

Forecast: 16:00 - $73.28

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $73.28
Forecast 2: 16:00 - $73.28
Forecast 3: 16:00 - $73.28
SCORE
-9.00
Sell
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $73.25 (0.33% )
Volume 8.24 mill
Avg. Vol. 7.53 mill
% of Avg. Vol 109.40 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Gilead Sciences Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Gilead Sciences Inc

RSI

Intraday RSI14 chart for Gilead Sciences Inc

Last 10 Buy & Sell Signals For GILD

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:36sell$73.74N/AActive
Profile picture for
            Gilead Sciences Inc

GILD

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

Last 10 Buy Signals

Date Signal @
WANETHUSDMar 29 - 03:533 523.63
KUBUSDMar 29 - 03:532.73
WTAOUSDMar 29 - 03:53524.24
NULSUSDMar 29 - 03:52$0.866
FLUXUSDMar 29 - 03:51$1.340
RADUSDMar 29 - 03:49$3.40
BTC2X-FLIUSDMar 29 - 03:5031.58
UNCXUSDMar 29 - 03:44328.38
TRIASUSDMar 29 - 03:4412.46
NANOUSDMar 29 - 03:45$1.656

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.